D.E. Siyutkin et al. / Tetrahedron 66 (2010) 513–518
517
Cbz-protected 4-hydroxy-(S)-proline (0.93 g, 3.50 mmol) and Et3N
(0.49 g, 3.50 mmol) in THF (20 mL) at 0–5 ꢀC. After 20 min a solu-
tion of (S)-diphenylvalinole (0.89 g, 3.50 mmol) in THF (10 mL) was
added dropwise during 10 min. The resulting mixture was stirred
for 2 h at 0–5 ꢀC and for 1 h at ambient temperature, then it was
filtrated off and washed with THF (15 mL). The combined organic
extracts were evaporated, and the residue was washed with Et2O
59.0, 58.8, 52.6, 49.3, 36.3, 35.2, 33.3, 29.3, 28.4, 22.8, 21.2, 18.6; IR
(KBr, cmꢂ1): 3350, 3148, 3064, 2956, 2872, 1732, 1704, 1560, 1448,
1420, 1356, 1168, 1120, 1064, 1004, 912; Elemental analysis calcd for
C39H47BrN4O6: C, 62.65; H, 6.34; Br,10.69; N, 7.49; O,12.84; found C,
62.83; H, 6.22; Br, 10.60; N, 7.54.
4.6. (4R)-(5-(1-Methyl-1H-imidazol-3-ium-3-yl))
pentanoyloxy)-(2S)-((1S)-(hydroxy-diphenyl-methyl)-2-
methyl-propylcarbamoyl]-pyrrolidine bromide 9
(2ꢁ10 mL) to afford 6 (1.60 g, 91%) as white solid, mp 219–221 ꢀC;
23
[
a]
ꢂ59.9 (c 0.67, i-PrOH); 1H NMR (300 MHz, CD3COCD3)
d: 7.61
D
(4H, d, J¼7.7 Hz, 2H2H6(Ph)), 7.09–7.43 (11H, m, 2H3–5(Ph),
C6H5(Cbz)), 5.10–5.29 (2H, m, CH2Ph), 4.88–4.98 (1H, m, CHNHCO),
4.16–4.36 (2H, m, CHO, CHCONH), 3.39–3.55 (2H, m, CH2N), 1.61–
2.01 (2H, m, CH2CHN), 1.25–1.58 (1H, m, CH(CH3)2), 0.70–1.07 (6H,
A mixture of 8 (0.90 g, 1.20 mmol) and Pd/C (5%, 0.09 g) in dry
CH3OH (25 mL) was stirred under H2 (760 Torr) at ambient temper-
ature for 3 h. The resulting precipitate was filtered off and washed
with CH3OH (10 mL). The combined organic phases were evaporated,
m, CH(CH3)2); 13C NMR (75.5 MHz, DMSO-d6)
d: 171.6, 154.0, 147.4,
146.0, 136.9, 128.2, 127.9, 127.4, 126.0, 125.8, 125.0, 81.1, 68.4, 65.7,
59.0, 57.8, 55.3, 37.7, 28.0, 22.7, 18.0; IR (KBr, cmꢂ1): 3364, 3292,
2956, 2944, 2872, 1660, 1524, 1432, 1352, 1304, 1180, 1124, 1156,
968, 912; Elemental analysis calcd for C30H34N2O5: C, 71.69; H, 6.82;
N, 5.57; O, 15.92; found C, 71.96; H, 6.75; N, 5.51.
and the residuewasdried invacuo (0.5 Torr) for 2 h to afford 9 (0.70 g,
22
95%) as white solid, mp 103–105 ꢀC; [
a]
D
ꢂ40.6 (c 1, CHCl3); 1H NMR
(300 MHz, CDCl3)
d
: 10.49 (1H, s, NCHN), 8.27 (1H, d, J¼10.3 Hz,
NCHCHN), 7.57 (4H, d, J¼7.3 Hz, 2H2H6(Ph)), 7.06–7.37 (7H, m, 2H3–
5(Ph), NCHCHN), 5.05–5.11 (1H, m, CHO), 4.77 (1H, dd, J1¼9.5 Hz,
J2¼2.6 Hz, CHNHCO), 4.37 (2H, t, J¼7.3 Hz, NCH2CH2), 4.05 (3H, s,
NCH3), 3.88 (2H, t, J¼8.4 Hz, CHCONH), 3.05 (1H, d, J¼12.8 Hz,
CHCHHN), 2.91 (1H, dd, J1¼13.0 Hz, J2¼3.8 Hz, CHCHHN), 2.37 (2H, t,
J¼7.0 Hz, CH2CO), 1.89–2.52 (2H, m, CH2CHN), 1.88–2.05 (2H, m,
CH2CH2N),1.60–1.74 (2H, m, CH2CH2CO),1.25–1.49 (1H, m, CH(CH3)2),
0.98 (3H, d, J¼6.6 Hz, CHCH3), 0.81 (3H, d, J¼7.0 Hz, CHCH3); 13C NMR
4.4. Benzyl (4R)-(5-Bromo-pentanoyloxy)-(2S)-((1S)-
(hydroxy-diphenyl-methyl)-2-methyl-propylcarbamoyl)-
pyrrolidine-1-carboxylate 7
A mixture of amide 6 (1.52 g, 3.03 mmol), 5-bromovaleric acid
(0.56 g, 3.09 mmol), DCC (0.63 g, 3.06 mmol) and DMAP (0.025 g,
0.20 mmol) in CH2Cl2 (20 mL) was stirred at 5 ꢀC for 8 h. The
resulting precipitate was filtered off and washed with CH2Cl2
(3ꢁ10 mL). The combined organic extracts were evaporated, and
the residue was purified by column chromatography on silica gel
(Acros, 0.035–0.070 mm, 60A, eluent: n-hexane/EtOAc¼4/1) and
(75.5 MHz, CDCl3) d: 173.4,172.1,147.2,145.6,136.8,128.9,127.9,127.7,
126.2, 125.6, 125.3, 123.3, 122.3, 81.5, 75.9, 59.6, 52.5, 49.3, 36.4, 33.2,
29.2, 28.5, 24.7, 22.8, 21.0,18.5;IR (KBr, cmꢂ1):3384, 3148, 2956, 2872,
1728, 1660, 1564, 1524, 1448, 1368, 1250, 1168, 1064, 1032; Elemental
analysis calcd for C31H41BrN4O4: C, 60.68; H, 6.74; Br, 13.02; N, 9.13;
O, 10.43; found C, 60.89; H, 6.68; Br, 13.00; N, 9.14.
dried in vacuo (0.5 Torr) for 2 h to afford bromoester 7 (1.49 g, 74%)
21
as white solid, mp 166–168 ꢀC; [
a]
ꢂ59.5 (c 1, CHCl3); 1H NMR
4.7. (4R)-(5-(1-Methyl-1H-imidazol-3-ium-3-yl))
pentanoyloxy)-(2S)-((1S)-(hydroxy-diphenyl-methyl)-2-
methyl-propylcarbamoyl]-pyrrolidine hexafluorophosphate 10
D
(300 MHz, CDCl3)
d
: 7.47 (4H, d, J¼5.1 Hz, 2H2H6(Ph)), 7.11–7.39
(11H, m, 2H3–5(Ph), C6H5(Cbz)), 5.11–5.23 (2H, m, CH2Ph), 4.83 (1H,
d, J¼10.3 Hz, CHNHCO), 4.25 (1H, t, J¼7.5 Hz, CHCONH), 4.07 (1H, d,
J¼7.7 Hz, CHO), 3.41–3.62 (2H, m, CH2N), 3.37 (2H, t, J¼6.4 Hz,
CH2Br), 3.17 (1H, s, OH), 2.26 (2H, t, J¼7.2 Hz, CH2CO),1.56–2.00 (6H,
m, (CH2)2CH2Br, CH2CHN), 1.26–1.45 (1H, m, CH(CH3)2), 0.76–0.97
A solution of KPF6 (0.10 g, 0.54 mmol) in water (5 mL) was added
to a solution of 9 (0.30 g, 0.49 mmol) in water (10 mL). The resulting
precipitate washed with distilled water (2ꢁ5 mL) and dried in vacuo
(6H, m, CH(CH3)2); 13C NMR (75.5 MHz, CDCl3)
d: 172.3, 171.1, 155.4,
(0.5 Torr) for 2 h to afford 10 (0.31 g, 93%) as while solid, mp 98–
22
146.5, 145.4, 136.3, 128.5, 128.4, 128.2, 128.0, 126.8, 125.4, 81.9, 72.8,
67.4, 59.2, 59.0, 52.3, 33.9, 33.1, 32.7, 31.8, 28.8, 23.3, 22.8, 18.0; IR
(KBr, cmꢂ1): 3400, 2960, 2928, 2872, 1732, 1700, 1660, 1532, 1420,
1356,1172,1128, 1064,1000, 972, 920, 892; Elemental analysis calcd
for C35H41BrN2O6: C, 63.16; H, 6.21; Br, 12.00; N, 4.21; O, 14.42;
found C, 63.40; H, 6.15; Br, 12.03; N, 4.17.
100 ꢀC; [
a
]
ꢂ30.6 (c 1, CHCl3); 1H NMR (300 MHz, CDCl3)
d: 8.46
D
(1H, s, NCHN), 7.98 (1H, d, J¼9.5 Hz, NCHCHN), 7.53 (4H, t, J¼8.2 Hz,
2H2H6(Ph)), 7.06–7.38 (7H, m, 2H3–5(Ph), NCHCHN), 5.01–5.08 (1H,
m, CHO), 4.69 (1H, d, J¼8.1 Hz, CHNHCO), 4.11 (2H, t, J¼7.3 Hz,
NCH2CH2), 3.82 (3H, s, NCH3), 3.78 (2H, t, J¼7.7 Hz, CHCONH), 3.05
(1H, d, J¼12.5 Hz, CHCHHN), 2.76 (1H, d, J¼11.8 Hz, CHCHHN), 2.30
(2H, t, J¼5.9 Hz, CH2CO), 1.95–2.38 (2H, m, CH2CHN), 1.79–1.92 (2H,
m, CH2CH2N), 1.49–1.64 (3H, m, CH2CH2CO, CH(CH3)2), 0.93 (3H, d,
J¼6.2 Hz, CHCH3), 0.83 (3H, d, J¼6.6 Hz, CHCH3); 13C NMR
4.5. Benzyl (4R)-(5-(1-Methyl-1H-imidazol-3-ium-3-yl))
pentanoyloxy)-(2S)-((1S)-(hydroxy-diphenyl-methyl)-2-
methyl-propylcarbamoyl]-pyrrolidine-1-carboxylate bromide 8
(75.5 MHz, CDCl3) d: 173.8, 172.2, 146.6, 145.2, 127.8, 127.5, 126.2,
125.2, 125.0, 123.1, 121.7, 81.0, 75.7, 59.3, 52.3, 48.9, 36.4, 35.5, 32.6,
28.4, 28.3, 22.5, 20.5, 17.9; IR (KBr, cmꢂ1): 3370, 3148, 2956, 2872,
1730,1664,1564,1524,1448,1368,1252,1168,1064,1032; Elemental
analysis calcd for C31H41F6N4O4P: C, 54.86; H, 6.09; F, 16.80; N, 8.26;
O, 9.43; P, 4.56; found C, 55.01; H, 6.03; F, 1659; N, 8.22.
A mixture of 7 (1.00 g, 1.50 mmol) and 1-methylimidazole
(0.30 g, 3.66 mmol) was heated at 100 ꢀC for 20 min with contin-
uous stirring and then cooled to ambient temperature. The
resulting viscous yellow oil became white solid as washed with
Et2O (6ꢁ10 mL). The precipitate was dried in vacuo (0.5 Torr) for 2 h
21
to afford 8 (1.02 g, 91%) as white solid, mp 131–133 ꢀC; [
a
]
ꢂ62.5
4.8. 4-Hydroxy-4-(4-nitrophenyl)-1-phenylbutan-2-one 15e
D
(c 1, CHCl3); 1H NMR (300 MHz, CDCl3)
d: 10.09 (1H, s, NCHN), 8.21
(1H, d, J¼10.3 Hz, NCHCHN), 7.54–7.66 (4H, m, 2H2H6(Ph)), 7.02–
7.40 (12H, m, 2H3–5(Ph), C6H5(Cbz), NCHCHN), 4.92–5.27 (4H, m,
CH2Ph, CHNHCO, CHO), 4.57 (1H, t, J¼8.3 Hz, CHCONH), 4.31–4.40
(2H, m, CH2CH2N), 3.96 (3H, s, CH3N), 3.56–3.79 (2H, m, CHCH2N),
2.24–2.42 (2H, m, CH2CO), 1.49–2.09 (6H, m, (CH2)2CH2N, CH2CHN),
1.30–1.45 (1H, m, CH(CH3)2), 0.69–1.14 (6H, m, (CH3)2CH); 13C NMR
Ee: 91%; mp 92–94 ꢀC; [ 21 36.2 (c 1, CHCl3); 1H NMR (300 MHz,
a]
D
CDCl3)
d
: 8.17 (2H, d, J¼8.4 Hz, H3H5(4-NO2-Ph)), 7.46 (2H, d,
J¼8.8 Hz, H2H6(4-NO2-Ph)), 7.11–7.39 (5H, m, C6H5), 5.22 (1H, t,
J¼5.7 Hz, CHOH), 3.74 (2H, s, PhCH2), 3.54 (1H, br, OH), 2.87 (2H, d,
J¼4.7 Hz, CH2CH); 13C NMR (75 MHz, CDCl3)
d: 208.1, 150.1, 147.2,
133.1,129.4,128.9,127.4,126.4,123.6, 69.0, 50.7, 49.8; IR (KBr, cmꢂ1):
3464, 1708, 1604, 1512, 1348, 1080, 1060, 852, 824; Rf¼0.66 (n-
hexane/EtOAc¼2/1); HPLC (Chiralcel OJ-H, n-hexane/i-PrOH¼7/3,
(75.5 MHz, CDCl3)
d: 171.9, 171.6, 154.6, 147.4, 145.7, 136.7, 128.3,
127.9, 127.5, 126.1, 125.6, 125.2, 123.2, 122.2, 120.3, 81.9, 73.2, 66.8,